Aphria Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aphria Inc with three other
pharmaceutical manufacturers in North America:
Oasmia Pharmaceutical AB
of UNITED STATES
sales of $20.97 million
Medexus Pharmaceuticals Inc
(74.36 million Canadian Dollars [US$55.70 million]
based in UNITED STATES
of which 100%
was commercial-stage diagnostics).
During the year ended May of 2020, sales at
Aphria Inc were C$543.34 million (US$406.99 million).
increase of 129.2%
versus 2019, when the company's sales were C$237.11 million.
This was the fifth consecutive year of sales increases at Aphria Inc
(and since 2015, sales have increased a total of 98,433%).
Sales of Businesses Under Development saw an increase
153.1% in 2020, from
C$326,000.00 to C$825,000.00 .